NU SKIN ENTERPRISES, INC. Segment Expenditure Addition To Long Lived Assets
NU SKIN ENTERPRISES, INC. (NUS) reported Segment Expenditure Addition To Long Lived Assets of $5.64 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Segment Reporting
us-gaap:SegmentExpenditureAdditionToLongLivedAssets · last filed 2026-08-10
- NU SKIN ENTERPRISES, INC. segment expenditure addition to long lived assets for the quarter ending 2026-06-30 was $5.64M, a 12.38% increase year-over-year.
- NU SKIN ENTERPRISES, INC. segment expenditure addition to long lived assets for the quarter ending 2026-03-31 was $13.71M, a 0.96% increase year-over-year.
- NU SKIN ENTERPRISES, INC. segment expenditure addition to long lived assets for the quarter ending 2025-12-31 was $10.76M, a 14.49% decline year-over-year.
- NU SKIN ENTERPRISES, INC. segment expenditure addition to long lived assets for the quarter ending 2025-09-30 was $9.91M, a 15.33% increase year-over-year.
- NU SKIN ENTERPRISES, INC. segment expenditure addition to long lived assets for fiscal 2025 was $34.28M, a 17.57% decline from fiscal 2024.
- NU SKIN ENTERPRISES, INC. segment expenditure addition to long lived assets for fiscal 2024 was $41.58M, a 28.91% decline from fiscal 2023.
- NU SKIN ENTERPRISES, INC. segment expenditure addition to long lived assets for fiscal 2023 was $58.49M, a 0.96% decline from fiscal 2022.
- NU SKIN ENTERPRISES, INC. segment expenditure addition to long lived assets for fiscal 2022 was $59.06M, a 13.93% decline from fiscal 2021.
| Period end | Segment Expenditure Addition To Long Lived Assets 3 month | Segment Expenditure Addition To Long Lived Assets 6 month | Segment Expenditure Addition To Long Lived Assets 9 month | Segment Expenditure Addition To Long Lived Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.64M 10-Q · filed 2026-08-10 | $19.35M 10-Q · filed 2026-08-10 | $30.11M derived: sum of 3 quarters · filed 2026-08-10 | $40.03M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $13.71M 10-Q · filed 2026-05-08 | $24.47M derived: sum of 2 quarters · filed 2026-05-08 | $34.39M derived: sum of 3 quarters · filed 2026-05-08 | $39.41M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $10.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $20.67M derived: sum of 2 quarters · filed 2026-02-13 | $25.69M derived: sum of 3 quarters · filed 2026-08-10 | $34.28M 10-K · filed 2026-02-13 |
| 2025-09-30 | $9.91M 10-Q · filed 2025-11-07 | $14.93M derived: sum of 2 quarters · filed 2026-08-10 | $23.52M 10-Q · filed 2025-11-07 | $41.10M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $5.02M 10-Q · filed 2026-08-10 | $13.60M 10-Q · filed 2026-08-10 | $31.18M derived: sum of 3 quarters · filed 2026-08-10 | $39.78M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $13.58M 10-Q · filed 2026-05-08 | $26.17M derived: sum of 2 quarters · filed 2026-05-08 | $34.76M derived: sum of 3 quarters · filed 2026-05-08 | $42.89M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $12.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $21.18M derived: sum of 2 quarters · filed 2026-02-13 | $29.30M derived: sum of 3 quarters · filed 2026-02-13 | $41.58M 10-K · filed 2026-02-13 |
| 2024-09-30 | $8.60M 10-Q · filed 2025-11-07 | $16.72M derived: sum of 2 quarters · filed 2025-11-07 | $29.00M 10-Q · filed 2025-11-07 | $49.38M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $8.12M 10-Q · filed 2025-08-08 | $20.40M 10-Q · filed 2025-08-08 | $40.79M derived: sum of 3 quarters · filed 2026-02-13 | $52.70M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $12.28M 10-Q · filed 2025-05-09 | $32.67M derived: sum of 2 quarters · filed 2026-02-13 | $44.57M derived: sum of 3 quarters · filed 2026-02-13 | $59.28M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $20.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $32.29M derived: sum of 2 quarters · filed 2026-02-13 | $47.00M derived: sum of 3 quarters · filed 2026-02-13 | $58.49M 10-K · filed 2026-02-13 |
| 2023-09-30 | $11.91M 10-Q · filed 2024-11-08 | $26.62M derived: sum of 2 quarters · filed 2024-11-08 | $38.10M 10-Q · filed 2024-11-08 | $51.89M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | $14.71M 10-Q · filed 2024-08-09 | $26.20M 10-Q · filed 2024-08-09 | $39.98M derived: sum of 3 quarters · filed 2025-02-14 | $65.44M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | $11.49M 10-Q · filed 2024-05-09 | $25.27M derived: sum of 2 quarters · filed 2025-02-14 | $50.72M derived: sum of 3 quarters · filed 2025-02-14 | $60.26M derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | $13.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $39.24M derived: sum of 2 quarters · filed 2025-02-14 | $48.78M derived: sum of 3 quarters · filed 2025-02-14 | $59.06M 10-K · filed 2025-02-14 |
| 2022-09-30 | $25.45M 10-Q · filed 2023-11-02 | $34.99M derived: sum of 2 quarters · filed 2023-11-02 | $45.27M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $9.54M 10-Q · filed 2023-08-02 | $19.82M 10-Q · filed 2023-08-02 | ||
| 2021-12-31 | $68.61M 10-K · filed 2024-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B | |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |